These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29863943)

  • 1. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid-onset piperacillin-tazobactam induced thrombocytopenia.
    Shaik S; Kazi HA; Ender PT
    J Pharm Pract; 2015 Apr; 28(2):204-6. PubMed ID: 25609660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY; Huang JC; Shen MC; Chuang SH; Lee MH; Chen HC
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
    He X; Huang W; Wan X; Li X; Chang Q; Ding L
    J Int Med Res; 2023 Mar; 51(3):3000605231162434. PubMed ID: 36967671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
    Gin A; Dilay L; Karlowsky JA; Walkty A; Rubinstein E; Zhanel GG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):365-83. PubMed ID: 17547502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report.
    Roh S; Hashimoto K; Kiriishi R; Matsubara K; Isozaki Y; Tanaka H; Kuwata T
    J Wound Care; 2024 Jun; 33(Sup6):S25-S30. PubMed ID: 38843043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
    LeClaire AC; Martin CA; Hoven AD
    Ann Pharmacother; 2004 Jun; 38(6):996-8. PubMed ID: 15113982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia caused by piperacillin/tazobactam.
    Pérez-Vázquez A; Pastor JM; Riancho JA
    Clin Infect Dis; 1998 Sep; 27(3):650-1. PubMed ID: 9770174
    [No Abstract]   [Full Text] [Related]  

  • 12. Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection.
    Uzun G; Onem Y; Hatipoglu M; Turhan V; Mutluoglu M; Ay H
    Scand J Infect Dis; 2013 Jan; 45(1):73-6. PubMed ID: 22746695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic anaemia caused by piperacillin-tazobactam.
    Dapper I; Nauwynck M; Selleslag D; Hidajat M; Bourgeois M; Martens P; Wilmer A
    Acta Clin Belg; 2009; 64(6):517-9. PubMed ID: 20101875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug fever due to piperacillin/tazobactam loaded into bone cement.
    Park HB; Choi JS; Park SH; Kee WJ; Koh YI
    J Korean Med Sci; 2011 Feb; 26(2):301-3. PubMed ID: 21286026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit.
    Bower M; Borders C; Schnure A; Groysman L; Tran MH
    World Neurosurg; 2018 Jun; 114():204-210. PubMed ID: 29555607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock.
    Tamme K; Oselin K; Kipper K; Tasa T; Metsvaht T; Karjagin J; Herodes K; Kern H; Starkopf J
    Acta Anaesthesiol Scand; 2016 Feb; 60(2):230-40. PubMed ID: 26830215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.
    Swe T; Ali M; Naing AT
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.
    Finsterer J; Kotzailias N
    Platelets; 2003 Aug; 14(5):329-31. PubMed ID: 12944250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa.
    Patel N; McNutt LA; Lodise TP
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2933-6. PubMed ID: 18519718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].
    Uji T; Hashimoto Y
    Nihon Yakurigaku Zasshi; 2009 Jun; 133(6):351-8. PubMed ID: 19521033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.